City Financial Investment Co Ltd

Q1 2018 13F Holdings Report, Restatement, Options Holdings

Signature - Title
Dallas McGillivray - Chief Compliance Officer
Location
London, United Kingdom
Options holdings as of
March 31, 2018
Notional value $
$555M
Number of holdings
17
Date filed
6/20/2018, 12:11 PM
Description
All US holdings of this investor are reported in this report.
Previous filing
Q4 2017 - Feb 14, 2018
Next filing
Q2 2018 - Aug 10, 2018
Stock holdings
Showing options holdings, see here for stock holdings
Sym Company Class Option Share Change Activity * Price $ Shares Notional Value
Filing 2018 Q1 - Restatement compared to 2017 Q4 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Dallas McGillivray Chief Compliance Officer London, United Kingdom 6/20/2018

Resubmission to correct Valeant Pharmaceuticals Intl Call (91911K102) position, To list APOLLO COML REAL EST FIN INC NOTE 5.500% 3/1 (03762UAA3) position that was missing from the original filing and to correct IQIYI Inc Sponsored ADS (46267X108) Value.